Reuters logo
BRIEF-Atossa Genetics announces upcoming Phase 2 study of topical Endoxifen
September 25, 2017 / 12:11 PM / 3 months ago

BRIEF-Atossa Genetics announces upcoming Phase 2 study of topical Endoxifen

Sept 25 (Reuters) - Atossa Genetics Inc

* Atossa Genetics announces upcoming Phase 2 study of topical Endoxifen

* Atossa Genetics - ‍ Atossa plans to apply for approval from Institutional Review Board and Swedish regulatory authority within next 30 days​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below